Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1.
| Data(s) |
2013
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_D3FB95DBF68C isbn:1572-0241 (Electronic) pmid:23821001 doi:10.1038/ajg.2013.140 isiid:000321305300024 |
| Idioma(s) |
en |
| Fonte |
American Journal of Gastroenterology, vol. 108, no. 7, pp. 1176-1178 |
| Tipo |
info:eu-repo/semantics/article article |
